Abdulkadir Keskinaslan, MD, MBA, MPH is Pricing Director for the Asia-Pacific, Middle East and African Countries at Novartis Pharma AG, Basel, Switzerland; leading price implementation for the whole Novartis portfolio in his region.
Dr. Keskinaslan gained his Medical Degree from Cerraphasa School of Medicine, Istanbul University, Turkey, and went on to complete his residency training in Family Medicine at Sisli Etfal Research and Training Hospital, Istanbul before studying for Masters Degrees in Business Administration at the Graduate School of Social Sciences, Yeditepe University, Istanbul, and Public Health in Health Care Management at Harvard School of Public Health, Boston, USA.
He has practiced medicine both in public and private settings - as a primary care physician, as a resident in tertiary care hospital and as an emergency room physician - before he joined the pharmaceutical industry focusing on health economics and pricing. His professional experience encompasses health economics activities across a range of therapy areas and his most recent appointment prior to his current role was as Senior Health Economics Manager in CVM at Novartis. His work focusing on “Observational and Real Life Effectiveness Studies” and “Compliance to Medicine” has been published in the international press and has been presented at national and international meetings. His recent areas of research are “Use of Health Economics for Pricing and Reimbursement Decision Making” and “Outcomes Based Innovative Pricing Schemes”.
In addition to his operational role in Novartis, Dr. Keskinaslan has been collaborating with Universities and Health Authorities in Asia Pacific, Middle East and Africa in organizing workshops and seminars to address health care priority issues.